AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2021

Jan 7, 2021

31046_dirs_2021-01-07_4c823d5a-ac7f-4493-babe-9fd7a1c3d37a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-05

Reporting Person: Hill Emily Luisa (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-05	Common Stock	S	112	$62.37	Disposed	13498	Direct
2021-01-05	Common Stock	S	176	$62.37	Disposed	13322	Direct

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 383 RSUs from a January 3, 2017 grant of 1,530 RSUs.

F2: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 600 RSUs from a January 3, 2018 grant of 2,400 RSUs